Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine

Improvement in pancreatic cancer treatment represents an urgent medical goal that has been hampered by the lack of predictive biomarkers. Circulating Tumor Cells (CTCs) may be able to overcome this issue by allowing the monitoring of therapeutic response and tumor aggressiveness through ex vivo expa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera-Báez, Lianette, Lohse, Ines, Lin, Eric, Raghavan, Shreya, Owen, Sarah, Harouaka, Ramdane, Herman, Kirk, Mehta, Geeta, Lawrence, Theodore S., Morgan, Meredith A., Cuneo, Kyle C., Nagrath, Sunitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225920/
https://www.ncbi.nlm.nih.gov/pubmed/32326109
http://dx.doi.org/10.3390/cancers12041011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225920/
https://www.ncbi.nlm.nih.gov/pubmed/32326109
http://dx.doi.org/10.3390/cancers12041011

Ejemplares similares